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Abstract
BACKGROUND
Very little is known about the role of extracorporeal membrane oxygenation
(ECMO) for the management of patients undergoing major aortic surgery with
particular reference to aortic dissection.
AIM
To review the available literature to determine if there was any evidence.
METHODS
A systematic literature search through PubMed and EMBASE was undertaken
according to specific key words.
RESULTS
The search resulted in 29 publications relevant to the subject: 1 brief
communication, 1 surgical technique report, 1 invited commentary, 1
retrospective case review, 1 observational study, 4 retrospective reviews, 13 case
reports and 7 conference abstracts. A total of 194 patients were included in these
publications of whom 77 survived.
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CONCLUSION
Although there is no compelling evidence for or against the use of ECMO in
major aortic surgery or dissection, it is enough to justify its use in this patient
population despite current adverse attitude.
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Core tip: The subject of our review remains controversial in the absence of clear
evidence but mainly based on opinions and speculations. We believe that such a timely
review may contribute to reconsider current thinking and address the subject with an
open mind.
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INTRODUCTION
Veno-arterial  extracorporeal membrane oxygenation (VA-ECMO) has become an
established and widely used technique to provide circulatory support for critically ill
patients with refractory cardiogenic shock and cardiac arrest[1-3] although an increased
left ventricular (LV) afterload may affect the intended beneficial effects[4]. The impact
of VA-ECMO on LV function can be explained in terms of pressure-volume (PV)
loops and Starling curves[5] following simulations based on a previously developed
model[6,7].  VA-ECMO does not  affect  LV function directly.  When LV afterload is
maintained constant at a specific systemic pressure, the Starling curve generated
before VA-ECMO support predicts the filling pressure related to any target stroke
volume (SV) at that systemic pressure. The mechanism by which that specific pressure
is achieved does not change the relationship between filling pressure and native LV
SV. A maintained Starling relationship during VA-ECMO support may help predict
ventricular distension and optimise the balance between LV unloading and systemic
perfusion[5]. Despite the outcome of the SHOCK II trial which remains against the use
of the intra-aortic balloon pump (IABP) in cardiogenic shock[8-10], a combined use of
VA-ECMO and IABP has shown reduced in-hospital mortality[11,12]. In addition, the
combination of VA-ECMO and the Impella device has been shown to be a useful
method to offload the left ventricle[13,14]. Quantitative evaluation based on a simulation
approach has confirmed the beneficial effect of adding IABP or Impella during VA-
ECMO support[15].
A recent retrospective multi-centre cohort study on post-cardiotomy VA-ECMO
has identified age, previous cardiac surgery, preoperative acute neurological events,
aortic arch surgery and increased arterial lactate as factors associated with increased
risk of early mortality following the procedure although the experience of the centre
may contribute to improved results[16]. Nevertheless, there is no real focus on critical
patients  experiencing  post-cardiotomy  failure  after  major  aortic  surgery  for
aneurysmal disease or dissection.
Diseases of the thoracic aorta carry a high mortality with an increasing prevalence
worldwide  at  present  in  the  context  of  long-standing  controversy  regarding  its
treatment[17-19]. Current evidence suggests that acute aortic syndromes are best treated
in dedicated, high-volume aortic centres[20]. Preoperative malperfusion plays a major
role on early and late outcome[21-23].
Therefore,  we  sought  to  review  current  attitude  on  the  use  of  mechanical
circulatory support (MCS) following major aortic surgery with a view that it may be
an option for these critical patients. The analysis has considered adult patients only.
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MATERIALS AND METHODS
This  review has  been undertaken according to  a  web-based literature  search on
PubMed and EMBASE using appropriately combined key words [extra-corporeal life
support (ECLS) and aortic surgery; ECLS and aortic dissection; ECMO and aortic
surgery; ECMO and aortic dissection]. The Participants, Intervention, Comparison,
Outcome and Study Design (PICOS) approach for the selection of clinical studies
following our systematic search has been used (Table 1). The PRISMA approach has
also  been  considered  whose  main  purpose  is  to  help  ensure  the  clarity  and
transparency  of  systematic  reviews;  it  was  developed  using  an  evidence-based
approach and is not intended as a quality assessment tool[24].  An extension of the
PRISMA statement  has  been  developed  to  specifically  address  the  reporting  of
systematic reviews incorporating network meta-analyses[25]. PRISMA-P is intended to
help the preparation and reporting of a robust protocol for a systematic review[26].
We selected all the articles including major aortic surgery involving the ascending
aorta, arch, descending thoracic and abdominal aorta.
The  aim  of  this  systematic  review  was  to  determine  current  knowledge  and
experience with ECLS/ECMO support for aortic disease and whether it is appropriate
for postcardiotomy failure following major aortic surgery with particular reference to
aortic dissection.
RESULTS
The search gave the following results (Figure 1): ECMO and aortic surgery retrieved
906 publications  in  PubMed and 13  publications  in  EMBASE;  ECMO and aortic
dissection retrieved 61 publications in PubMed and 49 in EMBASE; ECLS and aortic
surgery retrieved 67 publications in PubMed and no publications in EMBASE; ECLS
and aortic  dissection  retrieved  5  publications  in  PubMed and  2  publications  in
EMBASE.  The overall  analysis  revealed 29  publications  related to  the  subject  of
investigation as follows (Table 2):  1 brief  communication[27],  1  surgical  technique
report[28],  1 invited commentary[29],  1 retrospective case review[30],  1 observational
study[31], 4 retrospective studies[32-35], 13 case reports[36-48] and 7 conference abstracts[49-55].
The articles had been published between 1994 and 2019. Four publications reported
key data for this review[31-34]. A total number of 194 patients had been treated with
ECMO support leading to 77 surviving patients. Three publications[31,35,54]  did not
specify how many patients survived following ECMO support; therefore, the number
of surviving patients remains incomplete. Further analysis gives a breakdown of
aetiology, procedures performed and cannulation site when available (Table 3).
DISCUSSION
ECMO has become increasingly available for the treatment of a diverse population of
critically ill  patients and recent reviews have highlighted its  indications and the
evidence basis to justify its use[1,56]. VA-ECMO is a suitable approach in the context of
cardiac  failure.  Veno-venous  (VV)  ECMO is  appropriate  in  the  context  of  acute
respiratory disease syndrome.  More recently,  ECMO has been considered in the
setting  of  extracorporeal  cardiopulmonary  resuscitation.  Despite  increased
application of the technique, overall survival rates have remained unchanged with a
50%-70% range for respiratory support and 40%-60% range for cardiac support[57,58].
Traditional  configurations  for  ECMO support  include the  VV through the  right
internal jugular vein (Avalon cannula) and the veno-arterial (VA) either through the
ascending aorta and the right atrium (central cannulation) or through the femoral
vessels  (peripheral  cannulation)[3,59].  Hybrid  ECMO  configurations  have  been
increasingly  considered  recently  as  an  attempt  to  improve  outcome.  Triple
cannulation such as veno-venous-arterial (VVA) or venous-arterial-venous (VAV)
configurations may help with concomitant  cardiac  and respiratory failure.  VVA
ECMO consists of double venous cannulation through the right internal jugular vein
and the right femoral vein for drainage with right femoral artery cannulation for
perfusion. VAV ECMO consists of single venous drainage through the right femoral
vein with right femoral artery and right internal jugular vein for perfusion. The VPa
configuration through the insertion of a long venous cannula in the pulmonary artery,
usually via the right internal jugular vein, may be a suitable option for patients with
right heart failure[3].
Our literature search revealed a limited number of relevant articles as expected.
ECMO support following major aortic surgery has not been usually recommended
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Table 1  “Participants, Intervention, Comparison, Outcome and Study Design” approach for the
selection of clinical studies following systematic search
Participants Patients undergoing major aortic surgery for aneurysmal disease or dissection
Intervention VA-ECMO in patients requiring major aortic surgery for aneurysmal disease or dissection
Comparison Comparison with those who did not need ECMO support
Outcome If ECMO support made a difference
Study design Prospective and retrospective clinical studies; case series and case reports
ECMO:  Extra-corporeal  membrane  oxygenation;  VA-ECMO:  Veno-arterial  extracorporeal  membrane
oxygenation.
because of its potential to further exacerbate lesions of the aortic wall and increased
bleeding  with  delayed  thrombosis  of  the  false  lumen  due  to  the  use  of
anticoagulation[60-62].  Nevertheless, 3 retrospective studies[32-34]  and 1 observational
study[31] (Table 2) have shown the feasibility of ECMO support in patients undergoing
major aortic surgery for aneurysmal disease and dissection in contrast to current
scepticism[29]. In many countries the argument is to make for a balance between the
costs involved in running ECMO support and select those patients who would benefit
the  most  from a  period  of  circulatory  support  following  repair  for  acute  aortic
dissection. Monitoring the outcome of those patients who required ECMO support
postoperatively and develop a specific database may be the way forward to shed
further  lights  on the role  of  ECMO support  in  patients  undergoing major  aortic
surgery.  Although 1 retrospective study[34]  has reported 88% mortality rate in 35
patients who underwent ECMO support following surgical  treatment for type A
aortic dissection, there is no mention about indications for ECMO support; profile and
co-morbidities of these patients;  cannulation site (peripheral or central);  cause of
death. Twenty-seven patients received ECMO support on the day of surgery and 8
patients required ECMO support on postoperative day 1 or later. Most unusual, 4
additional patients with type A aortic dissection underwent ECMO support without
surgical  intervention  but  none  of  them  survived.  The  other  two  retrospective
studies[32,33] are more detailed with more favourable outcome in line with the extra
corporeal life support organization registry[57,58]. One study[33] included 36 patients
who required VA-ECMO for post-cardiotomy failure following major aortic surgery.
In-hospital mortality was 50% with multi-organ failure being the main cause of death.
Preoperative levels of CK-MB > 100 IU/L and peak lactate levels > 20 mmol/L were
considered relevant factors for in-hospital mortality. Retrograde flow cannulation was
identified  as  another  key  factor  for  reduced  survival  compared  to  antegrade
cannulation although the risk for early mortality is related to the preoperative clinical
and haemodynamic status rather than the cannulation technique[62]. The other study[32]
compared short- and long-term outcomes between patients who required ECMO
support and those who did not. In-hospital mortality was higher in the ECMO group
(65%)  compared  to  the  non-ECMO  group  (8.5%).  Preoperative  haemodynamic
instability, aortic cross-clamp time and postoperative peak CK-MB were identified as
predicting factors for postoperative ECMO support. ECMO survivors had younger
age  and less  postoperative  blood  transfusion.  Interestingly,  those  patients  who
survived after ECMO support following repair for acute type A aortic dissection
showed a long-term survival rate comparable to patients who did not require ECMO
support  postoperatively.  These  findings  were  confirmed  by  a  very  detailed
observational study[31] comparing patients with and without LV systolic dysfunction
who underwent surgical intervention for acute type A aortic dissection. A total of 510
patients were considered: 86 with LV systolic dysfunction (group I) and 424 patients
with preserved LV systolic function (group II).  ECMO support was required in 7
patients from group I and in 10 patients from group II. The overall mortality was 79
patients  out  of  510:  20 from group I  and 59 from group II.  Multivariate analysis
confirmed that  a  preoperative serum creatinine greater  than 1.5  mg/dL and the
requirement  for  ECMO support  intra-operatively  were  significant  independent
predictors of in-hospital mortality but survival following ECMO support was not
specified.  Although patients  with  preoperative  LV systolic  dysfunction showed
higher surgical risk for in-hospital mortality, their 3-year cumulative survival rate
(77.8%) was comparable with those with preserved LV systolic function (82.1%). Serial
echocardiographic  assessment  did not  show further  deterioration of  LV systolic
function during the 3-year follow-up.
To summarise the key factors related to the need for postoperative ECMO support
and outcome, the following have been identified.
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Figure 1
Figure 1  Summary of the steps followed during the literature search. ECLS: Extra-corporeal life support; ECMO:
Extra-corporeal membrane oxygenation.
Factors predicting the need for postoperative ECMO support[31,32,34]: Preoperative
haemodynamic  instability;  Myocardial  infarction;  Aortic  cross-clamp  time;
Cardiopulmonary  bypass  time;  Biventricular  systolic  dysfunction;  Inadequate
myocardial protection; Postoperative peak CK-MB; Propagation of the dissection into
the coronary arteries.
Factors related with survival following ECMO support[32,33]: Younger age; Reduced
postoperative blood transfusion; Lower level of preoperative CK-MB; Higher rate of
antegrade cannulation; Lower lactate levels at 12 h; Lower rate of continuous renal
replacement therapy; Longer intensive care stay.
Factors  related with adverse  outcome[31,33]:  Retrograde flow cannulation;  Peak
lactate levels > 20 mmol/L; Preoperative CK-MB > 100 IU/L; Combined aortic arch
replacement; Postoperative need of continuous renal replacement therapy; Prolonged
inotropic support; Visceral ischaemia; Limb ischaemia.
In conclusion, although there is no compelling evidence in favour or against the use
of ECMO support following major aortic surgery for aneurysmal disease or acute
aortic  dissection,  it  is  enough  to  justify  its  use  in  those  patients  who  develop
haemodynamic instability refractory to inotropic support.
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Table 2  Grading of manuscripts with key information and outcome
Ref. Study design/level of evidence ECMO patients Outcome
Abouliatim et al[27], 2012 Brief Communication; Level 3 AAA repair on ECMO support in 2
patients after failed EVAR
Both patients were discharged 12
days postoperatively
Lorusso et al[28], 2019 Surgical Technique; Level 3 2 patients requiring elective aortic
arch replacement and treated with
minimally invasive central ECMO,
which avoids re-sternotomy and
maintains antegrade blood flow
Successful outcome for both patients.
The technique is suitable only in
those patients where a side-armed
prosthetic graft had been used
Lazar et al[29], 2017 Invited commentary; Level 3 Comment to Sultan, 2017 with further
considerations about ECMO in aortic
dissection
Guenther et al[30], 2014 Retrospective Case Review; Level 3 6 patients with acute type A aortic
dissection involving the coronary
arteries treated with ECMO support
Mortality 67% (4 patients)
Lin et al[31], 2018 Observational Study; Level 2- 510 patients with TAAD between
2007 and 2018 17 required ECMO
postoperatively
Comparison between low LVEF and
preserved LVEF
Lin et al[32], 2017 Retrospective Study; Level 2- 162 patients underwent TAAD repair
between 2008 and 2015 20 patients
required ECMO support
postoperatively
Mortality: ECMO group 65%; non-
ECMO group 8.5%
Factors predicting postop ECMO:
haemodynamic instability; aortic
cross-clamp time; postop peak creat
kinase-MB
Younger age for ECMO survivors
Zhong et al[33], 2017 Retrospective Study; Level 2- 5637 patients underwent major aortic
surgery between 2009 and 2016 36
patients required ECMO support: 20
with TAAD; 3 Type B; 12 with
thoracic aortic aneurysm; 1 with CoA
(aortic coarctation)
Mortality 50%
Three main factors for in-hospital
mortality: retrograde-flow
cannulation; preop CK-MB level 100
IU/L; peak lactate level 20 mmol/L
Sultan et al[34], 2017 Retrospective Study; Level 2- Database review between 2004 and
2014 35 patients with Type A Aortic
Dissection (TAAD) underwent
ECMO support
Overall mortality 88%
There is no mention about indications
for ECMO support; profile and co-
morbidities of these patients;
cannulation site (peripheral or
central); cause of death
Guihaire et al[35], 2017 Retrospective Study; Level 2- 92 patients required ECMO support
following valve surgery (66%), acute
aortic dissection (10%) and CABG
(9%)
Survival for patients with aortic
dissection is not specified
Gennari et al[36], 2019 Case Report; Level 3 1 patient with iatrogenic type A
aortic dissection requiring ECMO
support
Successful weaning off ECMO after 4
days
Chatterjee et al[37], 2018 Case Report; Level 3 3 patients requiring ECMO support
after thoraco-abdominal aneurysm
repair
1 patient discharged after 128 days
but died 2 months later
1 patient discharged after 35 days
and alive at 3-year follow up
1 patient discharged after 19 days
and alive at 6-month follow up
Beyrouti et al[38], 2018 Case Report; Level 3 1patient with aortic dissection
involving the left main stem
requiring ECLS and subsequently
LVAD
Discharged after 27 days
Yukawa et al[39], 2018 Case Report; Level 3 Acute aortic dissection with out-of-
hospital cardiac arrest requiring
ECMO support
Discharged after 49 days
Stroehle et al[40], 2017 Case Report; Level 3 Traumatic aortic dissection treated
with TEVAR on ECMO support
Discharged after 42 days to neuro-
rehabilitation
Szczechowicz et al[41], 2016 Case Report; Level 3 2 patients with acute type A aortic
dissection complicated by right
ventricular failure requiring ECMO
support
First patient discharged after 27 days;
second patient discharged to the
ward after 8 days in ITU but no
mention about how many days
before discharge
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Ishida et al[42], 2015 Case Report; Level 3 Two-stage procedure on ECMO
support in 1 patient who sustained
type A acute aortic dissection in a
background of chronic thrombo-
embolic pulmonary hypertension
Prolonged hospital stay; no mention
how many days before discharge
Yavuz et al[43], 2015 Case Report; Level 3 ECMO following TEVAR in 1 patient No mention about outcome
Amako et al[44], 2013 Case Report; Level 3 1 patient with type A aortic
dissection treated with ECMO
support
ECMO weaned off after 65 hours
uneventfully
Doguet et al[45], 2010 Case Report; Level 3 1 patient with acute type A aortic
dissection involving the coronary
arteries treated with ECMO support
Discharged after 29 days
postoperatively
Koster et al[46], 2007 Case Report; Level 3 1 patient with acute type A aortic
dissection requiring ECMO support
who developed HIT treated
successfully with bivalirudin
LV recovery during VA-ECMO
support but RVAD required.
Successful ECMO weaning; RVAD
removed after 6 weeks
Fabricius et al[47], 2001 Case Report; Level 3 2 patients who sustained acute type
A aortic dissection during pregnancy
treated with ECMO support
Successful ECMO weaning
Yamashita et al[48], 1994 Case Report; Level 3 1 patient with acute aortic dissection
treated with ECMO support
Successful ECMO weaning
Jorgensen et al[49], 2019 Conference Abstract; Level 3 Elective femoro-femoral VA-ECMO
support for thoraco-abdominal aortic
aneurysm repair in a 82-year-old
patient
Discharged 11 days postoperatively
Heuts et al[50], 2017 Conference Abstract; Level 3 Surgical technique for ECMO
insertion (the Maastricht Approach)
See Lorusso, 2019 in this table
Yang et al[51], 2017 Conference Abstract; Level 3 Retrospective analysis of 1695
patients who underwent surgery for
aortic dissection between 2008 and
2015. 42 patients required VA-ECMO
support
30 patients were successfully weaned
off VA-ECMO and 19 patients were
discharged.
Higher lactate levels, pre-ECMO
cardiac arrest, major haemorrhage
and renal replacement therapy were
related to in-hospital mortality
Goldberg et al[52], 2017 Conference Abstract; Level 3 185 patients requiring repair of acute
type A aortic dissection between 2005
and 2016. 4 patients required VA-
ECMO support.
All 4 patients survived to hospital
discharge
Schmidt et al[53], 2016 Conference Abstract; Level 3 Acute type A aortic dissection
presenting as acute coronary
syndrome requiring ECMO support
in the cath lab as a bridge to surgical
intervention
Fatal outcome
Nierscher et al[54], 2012 Conference Abstract; Level 3 Observational study of patients
undergoing cardiac surgery in 2008.
35 patients required ECMO support.
Only one patient with aortic
dissection is reported.
Survival not specified for the patient
with aortic dissection
Shinar et al[55], 2011 Conference Abstract; Level 3 Observational study over a 14-mo
period of ECMO support initiated by
A&E physicians. The procedure was
attempted in 19 patients
Four patients were discharged
without neurological injury: 2
patients after MI, one after aortic
dissection with cardiac tamponade
and one after profound hypothermia
ECMO: Extra-corporeal membrane oxygenation; ECLS: Extra-corporeal life support; VA-ECMO: Veno-arterial extracorporeal membrane oxygenation.
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Table 3  Aetiology, type of procedure and type of cannulation
Ref. Study design/level of evidence ECMO patients
Lin et al[31], 2018 Observational Study; Level 2- 510 patients with ATAAD between 2007 and 2018
Entry Tear Exclusion     73.1%
Aortic Root Replacement    11.4%
Ascending Aorta Replacement   65.9%
Aortic Arch Replacement    25.3%
Hemiarch      13.3%
Total Arch      12.0%
Frozen Elephant Trunk     8.2%
Combined CABG      3.7%
17 required ECMO support but no procedure
break down is available
Lin et al[32], 2017 Retrospective Study; Level 2- 162 patients underwent type A aortic dissection
repair between 2008 and 2015
20 patients required ECMO support as follows:
Ascending Aorta Interposition graft  6
Aortic Root/Valve Procedure    9
Aortic Arch Procedure     10
Combined CABG      5
Combined Mitral Replacement/Repair  1
Combined Femoro-femoral crossover  1
Zhong et al[33], 2017 Retrospective Study; Level 2- 5637 patients underwent major aortic surgery
between 2009 and 2016 36 patients required
ECMO support as follows:
Type A aortic dissection    20
Type B aortic dissection     3
Thoracic aortic aneurysm    12
Aortic coarctation      1
Emergency surgery      9
Second operation      7
Ascending aorta replacement   34
Arch replacement      21
Descending aorta atenting    17
Thoraco-abdominal aorta replacement  2
Combined valve replacement   21
Combined CABG      16
Central ECMO cannulation    7
Peripheral ECMO cannulation   29
Femoro-femoral      20
Femoral vein to right axillary artery   7
Femoro-femoral + right axillary artery  2
IABP        9
Sultan et al[34], 2017 Retrospective Study; Level 2- Database review between 2004 and 2014
35 patients with type A aortic dissection
underwent ECMO support No procedure and
cannulation break down is available
Guihaire et al[35], 2017 Retrospective Study; Level 2- 92 patients underwent ECMO support between
January 2005 and December 2014 for post-
cardiotomy cardiogenic shock as follows:
Valve surgery       66%
Acute Aortic Dissection     10%
CABG       9%
Break down of procedures and cannulation is not
available
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Nierscher et al[54], 2012 Conference Abstract; Level 3 35 patients underwent ECMO support in 2008
following CABG (7), valve procedure (8), heart
transplant (8), LVAD insertion (1), combined
procedure (10), aortic dissection (1).
Cannulation was peripheral (23), central (7),
subclavian artery (5).
Gennari et al[36], 2019 Case Report; Level 3 1 patient with iatrogenic type A aortic dissection
requiring ECMO support through peripheral
cannulation. Ascending aorta replacement
including right coronary sinus with interposition
graft and single-vessel coronary artery bypass
grafting.
Jorgensen et al[49], 2019 Conference Abstract; Level 3 1 patient with thoraco-abdominal aortic aneurysm
requiring ECMO support through peripheral
cannulation. A multi-branched Gelweave Dacron
graft was used.
Chatterjee et al[37], 2018 Case Report; Level 3 3 patients requiring ECMO support after thoraco-
abdominal aneurysm repair.
2 patients had previous type A aortic dissection
repair; 1 patient had ascending aorta and
hemiarch replacement for type A aortic dissection
and subsequent TEVAR procedure. ECMO
cannulation between left axillary artery and
femoral vein (1 patient), femoro-femoral (2
patients).
Beyrouti et al[38], 2018 Case Report; Level 3 1 patient with aortic dissection involving the left
main stem treated with ascending aorta
interposition graft and CABG requiring ECLS
through central cannulation and subsequently
LVAD
Yukawa et al[39], 2018 Case Report; Level 3 Acute aortic dissection with out-of-hospital
cardiac arrest requiring ECMO support through
peripheral percutaneous femoral cannulation and
treated with ascending aorta replacement using an
interposition graft
Yang et al[51], 2017 Conference Abstract; Level 3 1695 patients underwent repair for aortic
dissection between 2008 and 2015. 42 patients
required ECMO support. Procedure and
cannulation break down is not available
Goldberg et al[52], 2017 Conference Abstract; Level 3 185 patients underwent surgical intervention for
acute type A aortic dissection between January
2005 and May 2016. 4 patients required VA-ECMO
support. Break down of procedures, concomitant
procedures and type of cannulation are not
available
Stroehle et al[40], 2017 Case Report; Level 3 Traumatic aortic dissection treated with TEVAR
on ECMO support
Schmidt et al[53], 2016 Conference Abstract; Level 3 Emergency ECMO insertion in the Cath Lab with
findings of type A acute aortic dissection resulting
in fatal outcome
Szczechowicz et al[41], 2016 Case Report; Level 3 2 patients with acute type A aortic dissection
complicated by right ventricular failure requiring
ECMO support
Ishida et al[42], 2015 Case Report; Level 3 Two-stage procedure on ECMO support in 1
patient who sustained acute type A aortic
dissection in a background of chronic thrombo-
embolic pulmonary hypertension
Yavuz et al[43], 2015 Case Report; Level 3 ECMO following TEVAR in 1 patient
Guenther et al[30], 2014 Retrospective Case Review; Level 3 6 patients with acute type A aortic dissection
involving the coronary arteries treated with
ECMO support
Amako et al[44], 2013 Case Report; Level 3 1 patient with acute type A aortic dissection
treated with ECMO support
Abouliatim et al[27], 2012 Brief Communication; Level 3 AAA repair on ECMO support in 2 patients after
failed EVAR
Shinar et al[55], 2011 Conference Abstract; Level 3 19 cases of ECMO insertion in Accident &
Emergency Department through percutaneous
cannulation of the femoral vessels
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Doguet et al[45], 2010 Case Report; Level 3 1 patient with acute type A aortic dissection
involving the coronary arteries treated with
peripheral ECMO support through femoro-
femoral cannulation. CABG as concomitant
procedure.
Koster et al[46], 2007 Case Report; Level 3 1 patient with acute type A aortic dissection
requiring ECMO support using bivalirudin
Fabricius et al[47], 2001 Case Report; Level 3 2 patients who sustained acute type A aortic
dissection during pregnancy treated with ECMO
support
Yamashita et al[48], 1994 Case Report ; Level 3 1 patient with acute aortic dissection treated with
ECMO support
ATAAD: Acute type A aortic dissection; ECMO: Extra-corporeal membrane oxygenation; TEVAR: Thoracic endo-vascular aortic repair; AAA: Abdominal
aortic aneurysm; EVAR: Endo-vascular aortic repair.
ARTICLE HIGHLIGHTS
Research background
Extra-corporeal membrane oxygenation (ECMO) support following major aortic surgery with
particular reference to aortic dissection remains controversial without clear direction. We aim to
shed some lights on the subject in order to make an impact and give a clear view that may well
lead to further studies.
Research motivation
We believe that a clear direction based on evidence may change current attitude.
Research objectives
Although ECMO support  is  not  perfect,  it  does  work when appropriately  considered and
performed. We believe it may become an additional option in aortic surgery.
Research methods
The methods have been already described in the article.
Research results
The results are promising and may lead to further studies to improve outcomes.
Research conclusions
There is enough evidence to support our statement although we would like to think that further
studies can be pursued to confirm our initial findings.
Research perspectives
There is potential to support further studies in the future.
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